Christine Biddick, Pa, | |
3500 W Chester Pike, Newtown Square, PA 19073-4101 | |
(610) 359-4400 | |
Not Available |
Full Name | Christine Biddick, Pa |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 3500 W Chester Pike, Newtown Square, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679201446 | NPI | - | NPPES |
PT030533 | Other | PA | PHYSICAL THERAPY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | PT030533 (Pennsylvania) | Secondary |
225100000X | Physical Therapist | PT030533 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christine Biddick, Pa, 11731 Ferndale St, Philadelphia, PA 19116-2035 Ph: (267) 671-0672 | Christine Biddick, Pa, 3500 W Chester Pike, Newtown Square, PA 19073-4101 Ph: (610) 359-4400 |
News Archive
According to the Centers for Disease Control and Prevention, 46 percent of children admitted to trauma centers for winter sports injuries have been diagnosed with a head injury – the majority of them from snowboarding, sledding, skiing, ice skating or ice hockey. Pediatric sports medicine is a growing field and is a direct response to how active today's children are in competitive and recreational sports.
A new joint agreement between The University of Texas at San Antonio and The University of Texas Health Science Center at San Antonio will make it easier for qualified students to enter nursing school.
Hygafem, Inc., the Georgia-based premier provider of touch-free workplace wellness technologies and services, has successfully launched its hand sanitizing program at Morehouse College in Atlanta, GA. Hygafem's touch-free hand sanitizing program decreases the risk of spreading disease, ensures safe and healthy facilities, and boosts satisfaction for students and employees at Morehouse College.
The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.
› Verified 5 days ago